Found: 120
Select item for more details and to access through your institution.
The development and validation of magnetic resonance elastography for fibrosis staging in primary sclerosing cholangitis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Liver stiffness increases acutely during sickle cell vaso-occlusive crisis.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 11, p. E250, doi. 10.1002/ajh.23532
- By:
- Publication type:
- Article
Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 4, p. 317, doi. 10.3390/cells8040317
- By:
- Publication type:
- Article
Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study.
- Published in:
- PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0201120
- By:
- Publication type:
- Article
Population-based estimate of hepatitis C virus prevalence in Ontario, Canada.
- Published in:
- PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0191184
- By:
- Publication type:
- Article
Noninvasive Tests of Fibrosis: To Get the Right Answers, We Need to Ask the Right Questions.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Risk of Hepatocellular Carcinoma After Spontaneous Clearance of Hepatitis C Virus and in Noncirrhosis Chronic Hepatitis C Patients With Sustained Virological Response: A Systematic Review.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S245, doi. 10.1093/cid/ciad380
- By:
- Publication type:
- Article
Ethics of Controlled Human Infection Studies With Hepatitis C Virus.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S216, doi. 10.1093/cid/ciad382
- By:
- Publication type:
- Article
First Do No Harm? Modeling Risks and Benefits of Challenge Trials for Hepatitis C Vaccine Development.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S231, doi. 10.1093/cid/ciad379
- By:
- Publication type:
- Article
Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design Considerations.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S262, doi. 10.1093/cid/ciad362
- By:
- Publication type:
- Article
Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Is It Time to Be Real?
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S215, doi. 10.1093/cid/ciad343
- By:
- Publication type:
- Article
Risk of Hepatocellular Carcinoma After Spontaneous Clearance of Hepatitis C Virus and in Noncirrhosis Chronic Hepatitis C Patients With Sustained Virological Response: A Systematic Review.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S245, doi. 10.1093/cid/ciad380
- By:
- Publication type:
- Article
Ethics of Controlled Human Infection Studies With Hepatitis C Virus.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S216, doi. 10.1093/cid/ciad382
- By:
- Publication type:
- Article
First Do No Harm? Modeling Risks and Benefits of Challenge Trials for Hepatitis C Vaccine Development.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S231, doi. 10.1093/cid/ciad379
- By:
- Publication type:
- Article
Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design Considerations.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S262, doi. 10.1093/cid/ciad362
- By:
- Publication type:
- Article
Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Is It Time to Be Real?
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S215, doi. 10.1093/cid/ciad343
- By:
- Publication type:
- Article
Don't Wait: The Benefits of Early Diagnosis in Perinatal Hepatitis C Virus Transmission.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 9, p. e3347, doi. 10.1093/cid/ciaa942
- By:
- Publication type:
- Article
Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian Registry.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 11, p. e799, doi. 10.1093/cid/ciaa1510
- By:
- Publication type:
- Article
Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 8, p. 1392, doi. 10.1093/cid/ciaa253
- By:
- Publication type:
- Article
Evaluation of Sustained Virologic Response as a Relevant Surrogate Endpoint for Long-term Outcomes of Hepatitis C Virus Infection.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 5, p. 780, doi. 10.1093/cid/ciaa144
- By:
- Publication type:
- Article
Hepatitis B Virus RNA as Early Predictor for Response to Pegylated Interferon Alpha in HBeAg-Negative Chronic Hepatitis B.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 2, p. 202, doi. 10.1093/cid/ciaa013
- By:
- Publication type:
- Article
Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 7, p. e115, doi. 10.1093/cid/ciz1089
- By:
- Publication type:
- Article
Patterns of Drug and Alcohol Use and Injection Equipment Sharing Among People With Recent Injecting Drug Use or Receiving Opioid Agonist Treatment During and Following Hepatitis C Virus Treatment With Direct-acting Antiviral Therapies: An International Study
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 11, p. 2369, doi. 10.1093/cid/ciz633
- By:
- Publication type:
- Article
What Is Needed to Move Toward Single-Step Diagnosis of Current HCV Infection?
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, p. S316, doi. 10.1093/infdis/jiad453
- By:
- Publication type:
- Article
Diagnostic Accuracy of Assays Using Point-of-Care Testing or Dried Blood Spot Samples for the Determination of Hepatitis C Virus RNA: A Systematic Review.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The Inflammatory Cytokine Profile Associated With Liver Damage Is Broader and Stronger in Patients With Chronic Hepatitis B Compared to Patients With Acute Hepatitis B.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Mechanism of action of interferon and ribavirin in treatment of hepatitis C.
- Published in:
- Nature, 2005, v. 436, n. 7053, p. 967, doi. 10.1038/nature04082
- By:
- Publication type:
- Article
Life Expectancy in Patients With Chronic HCV Infection and Cirrhosis Compared With a General Population.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 312, n. 18, p. 1927, doi. 10.1001/jama.2014.12627
- By:
- Publication type:
- Article
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Association Between Sustained Virological Response and AlI-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis.
- Published in:
- JAMA: Journal of the American Medical Association, 2012, v. 308, n. 24, p. 2584, doi. 10.1001/jama.2012.144878
- By:
- Publication type:
- Article
Durability of Response After Hepatitis B Surface Antigen Seroclearance During Nucleos(t)ide Analogue Treatment in a Multiethnic Cohort of Chronic Hepatitis B Patients: Results After Treatment Cessation.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 4, p. 680, doi. 10.1093/cid/cix353
- By:
- Publication type:
- Article
Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 1, p. 13, doi. 10.1093/cid/cix289
- By:
- Publication type:
- Article
Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 11, p. 1479, doi. 10.1093/cid/ciw579
- By:
- Publication type:
- Article
Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET Study.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 6, p. 776, doi. 10.1093/cid/ciw387
- By:
- Publication type:
- Article
Hepatitis C Virus Therapeutic Development: In Pursuit of "Perfectovir".
- Published in:
- Clinical Infectious Diseases, 2016, v. 62, n. 12, p. 1829, doi. 10.1093/cid/civ197
- By:
- Publication type:
- Article
Applicability of Hepatitis C Virus RNA Viral Load Thresholds for 8-Week Treatments in Patients With Chronic Hepatitis C Virus Genotype 1 Infection.
- Published in:
- Clinical Infectious Diseases, 2016, v. 62, n. 10, p. 1228, doi. 10.1093/cid/ciw061
- By:
- Publication type:
- Article
Hepatitis C Virus Therapeutic Development: In Pursuit of "Perfectovir".
- Published in:
- Clinical Infectious Diseases, 2015, v. 60, n. 12, p. 1829, doi. 10.1093/cid/civ197
- By:
- Publication type:
- Article
Editorial Commentary: Sustained Virologic Response for Patients With Hepatitis C–Related Cirrhosis: A Major Milestone, but Not Quite a Cure.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Impact of direct‐acting antiviral treatment on health utility in patients with chronic hepatitis C in hospital and community settings.
- Published in:
- Liver International, 2023, v. 43, n. 4, p. 805, doi. 10.1111/liv.15518
- By:
- Publication type:
- Article
Viral hepatitis C cascade of care: A population‐level comparison of immigrant and long‐term residents.
- Published in:
- Liver International, 2021, v. 41, n. 8, p. 1775, doi. 10.1111/liv.14840
- By:
- Publication type:
- Article
Progress towards hepatitis C virus elimination in high‐income countries: An updated analysis.
- Published in:
- Liver International, 2021, v. 41, n. 3, p. 456, doi. 10.1111/liv.14779
- By:
- Publication type:
- Article
Peri‐complication diagnosis of HCV among immigrants.
- Published in:
- Liver International, 2021, v. 41, n. 2, p. 421, doi. 10.1111/liv.14737
- By:
- Publication type:
- Article
Peri‐complication diagnosis of hepatitis C infection: Risk factors and trends over time.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 33, doi. 10.1111/liv.14670
- By:
- Publication type:
- Article
The emergency department as a setting‐specific opportunity for population‐based hepatitis C screening: An economic evaluation.
- Published in:
- Liver International, 2020, v. 40, n. 6, p. 1282, doi. 10.1111/liv.14458
- By:
- Publication type:
- Article
The health impact of delaying direct‐acting antiviral treatment for chronic hepatitis C: A decision‐analytic approach.
- Published in:
- Liver International, 2020, v. 40, n. 1, p. 51, doi. 10.1111/liv.14247
- By:
- Publication type:
- Article
Prevalence and predictors of complementary and alternative medicine modalities in patients with chronic hepatitis B.
- Published in:
- Liver International, 2019, v. 39, n. 8, p. 1418, doi. 10.1111/liv.14105
- By:
- Publication type:
- Article
Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin.
- Published in:
- Liver International, 2018, v. 38, n. 9, p. 1571, doi. 10.1111/liv.13708
- By:
- Publication type:
- Article
Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1‐6 and compensated cirrhosis or advanced fibrosis.
- Published in:
- Liver International, 2018, v. 38, n. 3, p. 443, doi. 10.1111/liv.13534
- By:
- Publication type:
- Article
Response to Cytoplasmic rods and rings in ribavirin and Cytoplasmic rods and rings in mycophenolic acid treatment.
- Published in:
- Liver International, 2017, v. 37, n. 11, p. 1743, doi. 10.1111/liv.13567
- By:
- Publication type:
- Article
Overcoming the resistance to resistance testing: Collecting the data.
- Published in:
- 2017
- By:
- Publication type:
- Editorial